Mon to Fri 08h00 to 16h30 ( UTC +2)

Mon to Fri 08h00 to 16h30 ( UTC +2)

Medicinal Product Regulation and Product Liability in South Africa

  1. Home
  2. /
  3. Intellectual Property
  4. /
  5. Patents
  6. /
  7. Medicinal Product Regulation and Product Liability in South Africa

Published Date: May 12, 2020

Medicinal product regulation and product liability in South Africa: overview by Danie Dohmen, Jenny Pienaar, Alexis Apostolidis and Jeanette Visagie

A Q&A guide to medicinal product regulation and product liability law in South Africa.

The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability.

To read the full Q&A, visit Thomsan Reuters Practical Law.

For information on pharmaceutical patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports, visit Pharmaceutical IP and Competition Law in South Africa: overview.

Alexis Apostolidis
Partner | Head of Competition Law Group
Danie Dohmen
Partner | Patent Attorney
Jenny Pienaar
Partner | Trade Mark Attorney

How can we help you?

We have offices in Pretoria, Johannesburg, Cape Town, and Durban, please contact your nearest office for any legal enquiry or assistance.

Related News & Insights